Clinical and cost-effectiveness of diagnostic strategies incorporating Beta-D-glucan (BDG) tests to reduce unnecessary use of empirical antifungal therapies for invasive Candida infection in the critical care setting : in response to an enquiry from The Scottish Antimicrobial Prescribing Group (SAPG).
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
Includes bibliographical references (pages 19-20).
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 25 June 2019)
Candidiasis
Nosocomial infections